DALLAS - s4story -- Lonestar Clinical Research is now enrolling participants for a clinical study in Dallas evaluating a new inhaler treatment for asthma. The study offers no-cost care, requires no insurance, and provides a chance for local residents to help shape the future of asthma treatment.

Asthma is a major health concern in the Dallas area, affecting nearly 1 in 10 residents. Each year, more than 8,000 emergency room visits in the Dallas region are linked to asthma-related complications.

"If you live with asthma, your experience matters," said Dr. Ebuh- principal investigator at Lonestar Clinical Research. "This study offers an opportunity to not only access potential new treatment options at no cost but also contribute to important research that could benefit others living with asthma in our community."

More on S For Story

• Pixel Studio Productions Launches Same-Day Headshots in Houston
• Exelon Leader Tamla Olivier Named 2025 Technologist of the Year by Waves of Change STEM Conference
• Be Part of the World's Largest Art Biennale | Moons, Castles, Trees | Copenhagen Chronotopes
• Chilling Sequel to Popular Children's Horror Series Launches August 1st
• SeedList Launching Institutional Crypto Crowdfunding Project to Empower Retail Investors and Disrupt the VC-Dominated Crypto Fundraising Landscape

Why This Study Matters:

• Asthma impacts thousands across Dallas
• A new inhaler is being evaluated for effectiveness and safety
• Your participation could help improve care for yourself and others
• No cost. No insurance needed. Compensation available.

To learn more about the study or find out if you qualify, visit https://joinlonestarasthmastudy.com/
or call Lonestar Clinical Research at 214-177-7722

About Lonestar Clinical Research
We strive to provide every volunteer with the best level of care. Our friendly, experienced, and knowledgeable staff members make sure that each patient is informed, comfortable, and satisfied with their participation in clinical research.